Centene Medical Costs Worry Investors -- Market Talk

Dow Jones
25 Apr

1013 ET - Centene's early share-price drop signals that reassuring words during its earnings call failed to soothe investors' worries about medical costs. The company stuck to its 2025 guidance but bumped up a measure of medical costs, and it flagged spending on high-cost drugs. Wall Street is concerned about the company's Medicaid business as well as the Affordable Care Act marketplace plans. Shares fall 7.3% to $57.10.(anna.mathews@wsj.com)

 

(END) Dow Jones Newswires

April 25, 2025 10:13 ET (14:13 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10